<DOC>
	<DOCNO>NCT01298050</DOCNO>
	<brief_summary>Extracorporeal membrane oxygenation ( ECMO ) support suggest improve survival rate patient refractory cardiac arrest ( CA ) . Recent study also highlight potential early application method improve prognosis prolong cardiac arrest hospital CA ( INHCA ) hospital CA ( OHCA ) . The rationale use ECMO patient optimize early perfusion vital organ , cure cause CA wait recovery injured myocardium . The investigator create flow-chart decide patient eligible . The aim study evaluate , flow-chart , investigator able detect patient probability survival .</brief_summary>
	<brief_title>Refractory IHCA OHCA Treated With ECMO</brief_title>
	<detailed_description />
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
	<criteria>Adults 1875 year old In hospital Witnessed Cardiac Arrest Noflow time &lt; 5 min . VF , VT , TP rhythm presentation Lowflow time &lt; 45 min . End Tidal CO2 &gt; 10 20 min.of CPR Comorbidities : Terminal Malignancy Aortic Dissection Severe Cardiac Failure without transplant indication Severe Aortic Valve Failure Known Severe Peripheral arteriopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>